This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, Q.
Right arrow Articles by Finn, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, Q.
Right arrow Articles by Finn, A.

 Previous Article  |  Next Article 

Infection and Immunity, May 2000, p. 2692-2697, Vol. 68, No. 5
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Mucosal Immune Responses to Meningococcal Group C Conjugate and Group A and C Polysaccharide Vaccines in Adolescents

Q. Zhang,* S. Choo, J. Everard, R. Jennings, and A. Finn

Sheffield Institute for Vaccine Studies, Division of Child Health, Children's Hospital, and Division of Molecular and Genetic Medicine, University of Sheffield, Sheffield, United Kingdom

Received 16 November 1999/Returned for modification 21 December 1999/Accepted 2 February 2000

Previous studies in children have shown that Haemophilus influenzae type b (Hib) polysaccharide conjugate vaccines can reduce nasopharyngeal carriage of H. influenzae and provide herd immunity and suggest that this effect is mediated through mucosal antibodies. As this phenomenon may operate in other invasive bacterial infections which are propagated by nasopharyngeal carriage, mucosal antibody responses to meningococcal C conjugate and A/C polysaccharide vaccines were investigated. A total of 106 school children aged 11 to 17 years were randomized to receive a single dose of either conjugate or polysaccharide vaccine in an observer-blind study. Before and at 1, 6, and 12 months after immunization, samples of unstimulated saliva were collected and assayed by enzyme-linked immunosorbent assay for group C polysaccharide-specific immunoglobulin A (IgA), IgA1, IgA2 and secretory component, IgG antibodies, and total IgG and IgA. A subset of serum samples were also assayed for specific IgA and IgG antibodies. The concentrations of specific IgA and IgG in saliva were expressed both as nanograms per milliliter and as nanograms per microgram of total IgA or IgG. One month after immunization, significant increases in antibody titers (both IgA and IgG) were observed in saliva in both groups. There were significant subsequent falls in antibody titers by 6 months. Anti-meningococcal C-specific secretory component and IgA antibody titers were closely correlated (r = 0.85, P < 0.001), but there was no significant correlation between salivary and serum IgA titers, suggesting that IgA antibodies are locally produced. Significant correlation was found between salivary and serum IgG titers (r = 0.52, P < 0.01), suggesting that salivary IgG may be serum derived. Compared with polysaccharide vaccine, the conjugate vaccine induced significantly higher salivary IgG responses (P < 0.05), although there were no significant differences between salivary IgA responses to the two vaccines. The conjugate vaccine induced greater salivary IgG responses than a polysaccharide vaccine. Both vaccines induced significant salivary IgA antibodies. Further studies are needed to establish the functional significance of these mucosal responses.

* Corresponding author. Mailing address: Division of Child Health, Children's Hospital, Sheffield S10 2TH, United Kingdom. Phone: (0044) (0) 114 2717419. Fax: (0044) (0) 114 2752505. E-mail: q.zhang{at}sheffield.ac.uk.

Infection and Immunity, May 2000, p. 2692-2697, Vol. 68, No. 5
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Pace, D., Pollard, A. J (2007). Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines. Arch. Dis. Child. 92: 909-915 [Abstract] [Full Text]  
  • Zhang, Q, Finn, A (2004). Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria. J. Clin. Pathol. 57: 1015-1021 [Abstract] [Full Text]  
  • Yazdankhah, S. P., Caugant, D. A. (2004). Neisseria meningitidis: an overview of the carriage state. J Med Microbiol 53: 821-832 [Abstract] [Full Text]  
  • Finn, A. (2004). Bacterial polysaccharide-protein conjugate vaccines. Br Med Bull 70: 1-14 [Abstract] [Full Text]  
  • Zhang, Q., Choo, S., Finn, A. (2002). Immune Responses to Novel Pneumococcal Proteins Pneumolysin, PspA, PsaA, and CbpA in Adenoidal B Cells from Children. Infect. Immun. 70: 5363-5369 [Abstract] [Full Text]  
  • Robinson, K., Neal, K. R., Howard, C., Stockton, J., Atkinson, K., Scarth, E., Moran, J., Robins, A., Todd, I., Kaczmarski, E., Gray, S., Muscat, I., Slack, R., Ala'Aldeen, D. A. A. (2002). Characterization of Humoral and Cellular Immune Responses Elicited by Meningococcal Carriage. Infect. Immun. 70: 1301-1309 [Abstract] [Full Text]  
  • Zhang, Q., Lakshman, R., Burkinshaw, R., Choo, S., Everard, J., Akhtar, S., Finn, A. (2001). Primary and Booster Mucosal Immune Responses to Meningococcal Group A and C Conjugate and Polysaccharide Vaccines Administered to University Students in the United Kingdom. Infect. Immun. 69: 4337-4341 [Abstract] [Full Text]  
  • MAcLENNAN, J (2001). Meningococcal group C conjugate vaccines. Arch. Dis. Child. 84: 383-386 [Full Text]  
  • De Wals, P., De Serres, G., Niyonsenga, T. (2001). Effectiveness of a Mass Immunization Campaign Against Serogroup C Meningococcal Disease in Quebec. JAMA 285: 177-181 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»